Artículos de revistas
A Putative Otu Domain-containing Protein 1 Deubiquitinating Enzyme Is Differentially Expressed In Thyroid Cancer And Identifies Less-aggressive Tumours
Registro en:
British Journal Of Cancer. Nature Publishing Group, v. 111, n. 3, p. 551 - 558, 2014.
70920
10.1038/bjc.2014.331
2-s2.0-84905262407
Autor
Carneiro A.P.
Reis C.F.
Morari E.C.
Maia Y.C.P.
Nascimento R.
Bonatto J.M.C.
De Souza M.A.
Goulart L.R.
Ward L.S.
Institución
Resumen
Background: This study aimed to identify novel biomarkers for thyroid carcinoma diagnosis and prognosis.Methods:We have constructed a human single-chain variable fragment (scFv) antibody library that was selected against tumour thyroid cells using the BRASIL method (biopanning and rapid analysis of selective interactive ligands) and phage display technology.Results:One highly reactive clone, scFv-C1, with specific binding to papillary thyroid tumour proteins was confirmed by ELISA, which was further tested against a tissue microarray that comprised of 229 thyroid tissues, including: 110 carcinomas (38 papillary thyroid carcinomas (PTCs), 42 follicular carcinomas, 30 follicular variants of PTC), 18 normal thyroid tissues, 49 nodular goitres (NG) and 52 follicular adenomas. The scFv-C1 was able to distinguish carcinomas from benign lesions (P=0.0001) and reacted preferentially against T1 and T2 tumour stages (P=0.0108). We have further identified an OTU domain-containing protein 1, DUBA-7 deubiquitinating enzyme as the scFv-binding antigen using two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.Conclusions:The strategy of screening and identifying a cell-surface-binding antibody against thyroid tissues was highly effective and resulted in a useful biomarker that recognises malignancy among thyroid nodules and may help identify lower-risk cases that can benefit from less-aggressive management. © 2014 Cancer Research UK. All rights reserved. 111 3 551 558 Andris-Widhopf, J., Rader, C., Steinberger, P., Fuller, R., Barbas Iii., C.F., Methods for the generation of chicken monoclonal antibody fragments by phage display (2000) J Immunol Methods, 242, pp. 159-181 Andris-Widhopf, J., Steinberger, P., Fuller, R., Rader, C., Barbas Iii., C.F., Generation of human scFv antibody libraries: PCR amplification and assembly of light-and heavy-chain coding sequences (2011) Cold Spring Harb Protoc, 2011, pp. 901-922 Berger, M., Shankar, V., Vafai, A., Therapeutic applications of monoclonal antibodies (2002) Am J Med Sci, 324, pp. 14-30 Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Mazzaferri, E.L., Tuttle, R.M., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214 Cosimi, A.B., Colvin, R.B., Burton, R.C., Rubin, R.H., Goldstein, G., Kung, P.C., Hansen, W.P., Russell, P.S., Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts (1981) N Engl J Med, 305, pp. 308-314 Cunha, L.L., Morari, E.C., Guihen, A.C., Razolli, D., Gerhard, R., Nonogaki, S., Soares, F.A., Ward, L.S., Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma (2012) Clin Endocrinol (Oxf), 77, pp. 918-925 Cunha, L.L., Morari, E.C., Nonogaki, S., Soares, F.A., Vassallo, J., Ward, L.S., Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas (2012) Clinics (Sao Paulo), 67, pp. 483-488 Davies, L., Welch, H.G., Thyroid cancer survival in the United States: Observational data from 1973 to 2005 (2010) Arch Otolaryngol Head Neck Surg, 136, pp. 440-444 Flego, M., Ascione, A., Zamboni, S., Dupuis, M.L., Imperiale, V., Cianfriglia, M., Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells (2007) BMC Biotechnol, 7, p. 38 Giordano, R.J., Cardo-Vila, M., Lahdenranta, J., Pasqualini, R., Arap, W., Biopanning and rapid analysis of selective interactive ligands (2001) Nat Med, 7, pp. 1249-1253 Gorbenko, O., Ovcharenko, G., Klymenko, T., Zhyvoloup, O., Gaman, N., Volkova, D., Gout, I., Filonenko, V., Generation of monoclonal antibody targeting fibroblast growth factor receptor 3 (2009) Hybridoma (Larchmt), 28, pp. 295-300 Guth, S., Theune, U., Aberle, J., Galach, A., Bamberger, C.M., Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination (2009) Eur J Clin Invest, 39, pp. 699-706 Kilfoy, B.A., Zheng, T., Holford, T.R., Han, X., Ward, M.H., Sjodin, A., Zhang, Y., Rothman, N., International patterns and trends in thyroid cancer incidence, 1973-2002 (2009) Cancer Causes Control, 20, pp. 525-531 Lipes, B.D., Chen, Y.H., Ma, H., Staats, H.F., Kenan, D.J., Gunn, M.D., An entirely cell-based system to generate single-chain antibodies against cell surface receptors (2008) J Mol Biol, 379, pp. 261-272 Makarova, K.S., Aravind, L., Koonin, E.V., A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae (2000) Trends Biochem Sci, 25, pp. 50-52 Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., Winter, G., By-passing immunization. Human antibodies from V-gene libraries displayed on phage (1991) J Mol Biol, 222, pp. 581-597 Martinez-Torrecuadrada, J., Cifuentes, G., Lopez-Serra, P., Saenz, P., Martinez, A., Casal, J.I., Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation (2005) Clin Cancer Res, 11, pp. 6280-6290 Miller, K.D., Weaver-Feldhaus, J., Gray, S.A., Siegel, R.W., Feldhaus, M.J., Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coli (2005) Protein Expr Purif, 42, pp. 255-267 Piana, S., Frasoldati, A., Ferrari, M., Valcavi, R., Froio, E., Barbieri, V., Pedroni, C., Gardini, G., Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007 (2011) Cytopathology, 22, pp. 164-173 Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Eilers, M., The ubiquitin-specific protease USP28 is required for MYC stability (2007) Nat Cell Biol, 9, pp. 765-774 Priolo, C., Tang, D., Brahamandan, M., Benassi, B., Sicinska, E., Ogino, S., Farsetti, A., Loda, M., The isopeptidase USP2a protects human prostate cancer from apoptosis (2006) Cancer Res, 66, pp. 8625-8632 Rader, C., Barbas Iii., C.F., Phage display of combinatorial antibody libraries (1997) Curr Opin Biotechnol, 8, pp. 503-508 Rauchenberger, R., Borges, E., Thomassen-Wolf, E., Rom, E., Adar, R., Yaniv, Y., Malka, M., Rothe, C., Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3 (2003) J Biol Chem, 278, pp. 38194-38205 Retter, I., Althaus, H.H., Munch, R., Muller, W., VBASE2, an integrative v gene database (2005) Nucleic Acids Res, 33, pp. D671-D674 Roessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M.L., Palme, S., Berndt, P., Engel, A.M., Tacke, M., Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis (2006) Mol Cell Proteomics, 5, pp. 2092-2101 Rosario, P.W., Ward, L.S., Carvalho, G.A., Graf, H., Maciel, R.M., Maciel, L.M., Maia, A.L., Vaisman, M., Thyroid nodules and differentiated thyroid cancer: Update on the Brazilian consensus (2013) Arq Bras Endocrinol Metabol, 57, pp. 240-264 Schwickart, M., Huang, X., Lill, J.R., Liu, J., Ferrando, R., French, D.M., Maecker, H., Dixit, V.M., Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival (2010) Nature, 463, pp. 103-107 Seymour, J.F., New treatment approaches to indolent non-Hodgkin's lymphoma (2004) Semin Oncol, 31, pp. 27-32 Varandas, V.M., Coelho, S.M., Soeiro, A.P., Coeli, C.M., Carvalho, D.P., Buescu, A., Vaisman, M., Clinical repercussion of the 6th edition TNM staging system classification on differentiated thyroid carcinoma (2007) Arq Bras Endocrinol Metabol, 51, pp. 825-831 Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., Mann, M., Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry (1996) Nature, 379, pp. 466-469 Wolf, P., Gierschner, D., Buhler, P., Wetterauer, U., Elsasser-Beile, U., A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells (2006) Cancer Immunol Immunother, 55, pp. 1367-1373 Yang, J.M., Emerging roles of deubiquitinating enzymes in human cancer (2007) Acta Pharmacol Sin, 28, pp. 1325-1330